Request Demo
Last update 12 Apr 2025
RG-CLDN18.2
Last update 12 Apr 2025
Overview
Basic Info
Drug Type CAR-NK |
Synonyms Cord Blood-Derived CAR-NK Cells Targeting Claudin18.2(Hangzhou RonGu Biotechnology Limited Company), Cord Blood-Derived CAR-NK Cells(Hangzhou RonGu Biotechnology Limited Company) |
Target |
Action modulators |
Mechanism CLDN18.2 modulators(Claudin 18.2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with RG-CLDN18.2NCT06464965
A Phase I Clinical Study of Cord Blood-Derived CAR-NK Cells Targeting Claudin18.2 in the Treatment of Advanced Gastric Cancer and Advanced Pancreatic Cancer
100 Clinical Results associated with RG-CLDN18.2
Login to view more data
100 Translational Medicine associated with RG-CLDN18.2
Login to view more data
100 Patents (Medical) associated with RG-CLDN18.2
Login to view more data
100 Deals associated with RG-CLDN18.2
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced gastric carcinoma | Phase 1 | China | - | 19 Jul 2024 |
| Pancreatic Adenoma | Phase 1 | China | - | 19 Jul 2024 |
| Stomach Cancer | Preclinical | China | 27 Oct 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free